New $13.8M center at U-M will study infectious disease, pandemic preparedness

Author | Kelly Malcom

As researchers around the world continue to combat the COVID-19 pandemic, most agree on one issue: If history is any indication, there's another pandemic coming.

"Since 2000, we've had three coronaviruses that are new to humans cause outbreaks or the current pandemic. And we've had three influenza viruses try to make the jump from animals to humans, and one succeeded, said Aubree Gordon, an infectious disease expert at the University of Michigan School of Public Health. "So what's the likelihood that we see another pandemic in our lives? I'll say the likelihood is pretty high."

To better prepare for it, maximizing U-M's breadth of scientific expertise and collaboration across campus and supporting the increase of human and lab infrastructure, the Biosciences Initiative is awarding $13.8 million over five years to the new Michigan Center for Infectious Disease Threats

The center, led by Gordon, will allow researchers from public health, engineering, medicine, evolutionary biology and social sciences to work across disciplines on issues key to infectious disease preparedness and response, including public health workforce development, increasing lab capacity, expanding protein production for disease-testing capacity and adding testing of zoonotic pathogens.

"The overall objective of the center is to connect researchers here on campus and better prepare the University of Michigan both locally and globally for pandemic preparedness and response, to create a community here on campus revolving around infectious disease," said Gordon, associate professor of epidemiology. "The center will create synergies across our multiple schools and departments and make us competitive for the recruitment of scientists to fill critical research area gaps."

The center programs will include:

  • A Workforce Development Initiative to strengthen the strategic skills and capacity of the public health workforce to develop integrated training in public health practices to address infectious disease threats in Michigan.
  • In collaboration with the U-M Medical School and School of Public Health, the center will develop enhanced Biosafety Level 3 capabilities, dramatically increasing the resources available to the U-M infectious disease community.  Activities to expand the state-of-the-art BSL3 containment space have already begun and it's expected to open to investigators in early 2022.
  • The Ecology and Evolutionary Biology Museum's Pathogen Biorepository will leverage the collection's 100,000 tissue samples already in existence and add to the collection of samples for infectious disease detection. While the initial focus will be on bats, rodents and aquatic birds, they expect to include all wildlife groups.
  • The Protein Production Initiative will provide a rapid response facility for the production of proteins from emergent pathogens for use in serological testing and research, which was key during the early testing challenges during the COVID-19 pandemic. This program uses expertise from the LSI Centers for Structural Biology and Cryoelectron microscopy. 

Gordon said many, including Bill Gates in a famous 2015 TEDx video, had warned that the U.S. was not ready for the next pandemic. Then, SARS-CoV-2 happened.

"The world was not ready for the pandemic, our nation was not ready for the pandemic and our campus was not ready for the pandemic," she said. 

Gordon said U-M has exceptionally strong programs in many areas required to make it a leader in emerging and reemerging infectious diseases, such as virology, immunology, bioengineering, infectious disease epidemiology, mathematical modeling and pharmaceutical sciences. And the university also is a nationally leading center for social science research and public policy, areas that are not traditionally thought of as infectious disease, but have been critical for pandemic response, she said.

Until now, there was no structure to align these efforts. According to Roger Cone, director of the Biosciences Initiative, "the MCIDT is a great example of what the initiative was designed to do, bring together scientists across the breadth of U-M to address critical emerging problems in the life sciences."

"We hope that with this funding, when the next pandemic hits, we will be at the ready, with all the resources of the university at our disposal to provide the best response possible," Gordon said.

Contact: Nardy Baeza Bickel, 734-763-0368, [email protected]

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Study Shows Medical Marijuana Use Decreased in States with Legalized Recreational Use
The number of patients using cannabis for medical purposes has increased more than 600 percent since 2016.
Illustration of a microscope
Health Lab
Helpful enzymes vanish in many patients with antiphospholipid syndrome
Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.
marijuana leaf drawing blue lab note yellow badge upper left corner
Health Lab
Data shows medical marijuana use decreased in states where recreational use became legal 
Data on medical cannabis use found that enrollment in medical cannabis programs increased overall between 2016 and 2022, but enrollment in states where nonmedical use of cannabis became legal saw a decrease in enrollment
Illustration of hand holding list, with pill bottle in opposite and and small pic of doctor talking to patient
Health Lab
New urine-based test detects high grade prostate cancer, helping men avoid unnecessary biopsies
A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.
hospital.jpg
News Release
Michigan Medicine part of research group awarded $15 million to study inflammation's impact on heart, brain health
Research teams from Michigan Medicine, Northwestern University and University of Pittsburgh will lead a $15 million project dedicated to studying inflammation’s role in cardiac and brain diseases. The specific work by Michigan Medicine will focus on the driving forces behind inflammatory processes linked to aging and obesity and how to prevent inflammation that could lead to heart failure, dementia and other diseases.
Florescent image of a human ovarian follicle
Health Lab
Spatial atlas of the human ovary with cell-level resolution will bolster reproductive research
New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.